features: Perspectives

Therapeutic plasma exchange with albumin replacement to slow cognitive decline in Alzheimer’s disease

The results of the Phase III AMBAR trial were presented at the 2021 EAN meeting. Read on to learn more…

Read More
The content of VJNeurology is intended for healthcare professionals